{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02640118","recordId":"NCT02640118","peptideSlug":"lixisenatide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02640118-lixisenatide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02640118.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02640118.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2015-12-21","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ENROLLING_BY_INVITATION","peptideSlug":"lixisenatide","submittedDate":"2015-12-21","publishedAt":"2026-08-23","recordId":"NCT02640118","recordSha256":"192a191f2581622161b1f077547345f278c03675064f09d84e2053515311743e","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02640118?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Design","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2016-10-24","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lixisenatide","submittedDate":"2016-10-24","publishedAt":"2026-08-23","recordId":"NCT02640118","recordSha256":"4bc21f4c98a03bcf1006b7422089937dbf2c16d89bb988adc34dc9279f667fcf","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02640118?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Outcome Measures","Study Status"],"historyVersion":3,"lastUpdateSubmitQcDate":"2019-06-19","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lixisenatide","submittedDate":"2019-06-19","publishedAt":"2026-08-23","recordId":"NCT02640118","recordSha256":"6ab2a3ae54d9f5e72721e2bf395382345695ea35660b1877c897913474eca391","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02640118?a=3&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2020-05-06","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"lixisenatide","submittedDate":"2020-05-06","publishedAt":"2026-08-23","recordId":"NCT02640118","recordSha256":"6590c65ba2b2f2a83ea2978528fbb4c3d3a3aea8dc76d2041474653cd9b6939f","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02640118?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"399bccf46f33a380731400fc0ba49f0ff4c3bc46f82ca1aff9e3ee56ea8708ab"}}